Thanks Enjay. From BuildGoodThings on Reddit, I

Quote:

---

This is hot off the presses. So we did have an EIND subject, a 53 year old woman who was diagnosed with TNBC in March of 2021. PD-L1 and tumor cells. You can kind of go through the list here. I think she, you know is fourth line now, but on July 1st, sorry, on April 15th she began, Leronlimab 700mg dose weekly, to present.

And then on July 1st through liquid biopsy results, she was determined to be medium high PD-L1expression, and therefore her insurance actually approved her to go on Keytruda. So it will be really interesting to follow this patient to see if she follows through and is able to, see what those other five women that I mentioned, are able to as well.

---